Global Neuromuscular Disease Therapeutics Market 2025-2029
상품코드:1626440
리서치사:TechNavio
발행일:2024년 12월
페이지 정보:영문 195 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
신경근 질환 치료 시장, 2025-2029년
신경근 질환 치료 시장은 2024-2029년에 137억 2,750만 달러, 예측 기간 중 CAGR은 14.6%로 성장할 것으로 예측됩니다. 신경근 질환 치료 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개의 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 신경근 질환 치료의 신규 승인, 신생아 스크리닝 검사에 대한 요구의 증가, 신경근 질환 치료에 대한 방대한 미충족 요구가 시장을 촉진하고 있습니다.
시장 범위
기준년
2025년
종료년
2029년
예측 기간
2025-2029년
성장 모멘텀
가속
전년대비[2025년]
11.6%
CAGR
14.6%
증분액
137억 2,750만 달러
본 조사에서는 향후 수년간 신경근 질환 치료 시장 성장을 촉진하는 주요 요인의 하나로 신경근 질환 치료에서의 기술 진보를 들고 있습니다. 또한 신경근 질환의 유전적 성질 및 신경근 질환 치료 개발 연구의 증가는 시장의 큰 수요로 연결됩니다.
The neuromuscular disease therapeutics market is forecasted to grow by USD 13727.5 mn during 2024-2029, accelerating at a CAGR of 14.6% during the forecast period. The report on the neuromuscular disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by novel approvals for neuromuscular disease therapeutics, increasing need for newborn screening tests, and huge unmet need for neuromuscular disease therapeutics.
Market Scope
Base Year
2025
End Year
2029
Series Year
2025-2029
Growth Momentum
Accelerate
YOY 2025
11.6%
CAGR
14.6%
Incremental Value
$13727.5 mn
Technavio's neuromuscular disease therapeutics market is segmented as below:
By End-user
Hospitals
Clinics
Others
By Type
Biologics
Small molecules
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the technological advances in neuromuscular disease therapy as one of the prime reasons driving the neuromuscular disease therapeutics market growth during the next few years. Also, inherited nature of neuromuscular diseases and increasing research on developing therapeutics for neuromuscular disease will lead to sizable demand in the market.
The report on the neuromuscular disease therapeutics market covers the following areas:
Neuromuscular Disease Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuromuscular disease therapeutics market vendors that include AbbVie Inc., Aquestive Therapeutics Inc, argenx SE, AstraZeneca Plc, Biogen Inc., CuraVac, F. Hoffmann La Roche Ltd., Grifols SA, Merck and Co. Inc., Nippon Shinyaku Co. Ltd., Novartis AG, Pfizer Inc., Roivant Sciences Ltd., Santhera Pharmaceuticals Holding AG, Sarepta Therapeutics Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the neuromuscular disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Neuromuscular Disease Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Neuromuscular Disease Therapeutics Market 2019 - 2023 ($ million)
